We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Cipher Pharmaceuticals Inc. today announced it has acquired from Aclaris Therapeutics, Inc. the exclusive Canadian rights to distribute and commercialize A-101 40% topical solution ("A-101 40%").